Evaluation of dyspepsia

Vakil NB, Halling K, Becher A, et al. Systematic review of patient-reported outcome instruments for gastroesophageal reflux disease symptoms. Eur J Gastroenterol Hepatol. 2013 Jan;25(1):2-14. Abstract

World Gastroenterology Organisation. World Gastroenterology Organisation global guidelines: coping with common GI symptoms in the community. May 2013 [internet publication].Full text

Moayyedi PM, Lacy BE, Andrews CN, et al. ACG and CAG clinical guideline: management of dyspepsia. Am J Gastroenterol. 2017 Jul;112(7):988-1013.Full text  Abstract

Talley NJ, Vakil NB, Moayyedi P. AGA technical review: evaluation of dyspepsia. Gastroenterology. 2005 Nov;129(5):1756-80.Full text  Abstract

National Institute for Health and Care Excellence. Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management. Oct 2019 [internet publication].Full text

Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006 Aug;101(8):1900-20. Abstract

Stanghellini V, Chan FK, Hasler WL, et al. Gastroduodenal disorders. Gastroenterology. 2016 May;150(6):1380-92. Abstract

Moayyedi PM, Lacy BE, Andrews CN, et al. ACG and CAG clinical guideline: management of dyspepsia. Am J Gastroenterol. 2017 Jul;112(7):988-1013.Full text  Abstract

1. Vakil NB, Halling K, Becher A, et al. Systematic review of patient-reported outcome instruments for gastroesophageal reflux disease symptoms. Eur J Gastroenterol Hepatol. 2013 Jan;25(1):2-14. Abstract

2. World Gastroenterology Organisation. World Gastroenterology Organisation global guidelines: coping with common GI symptoms in the community. May 2013 [internet publication].Full text

3. Moayyedi PM, Lacy BE, Andrews CN, et al. ACG and CAG clinical guideline: management of dyspepsia. Am J Gastroenterol. 2017 Jul;112(7):988-1013.Full text  Abstract

4. Talley NJ, Vakil NB, Moayyedi P. AGA technical review: evaluation of dyspepsia. Gastroenterology. 2005 Nov;129(5):1756-80.Full text  Abstract

5. National Institute for Health and Care Excellence. Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management. Oct 2019 [internet publication].Full text

6. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006 Aug;101(8):1900-20. Abstract

7. Stanghellini V, Chan FK, Hasler WL, et al. Gastroduodenal disorders. Gastroenterology. 2016 May;150(6):1380-92. Abstract

8. Ford AC, Marwaha A, Sood R, et al. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut. 2015 Jul;64(7):1049-57. Abstract

9. Aziz I, Palsson OS, Törnblom H, et al. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study. Lancet Gastroenterol Hepatol. 2018 Apr;3(4):252-62. Abstract

10. Flier SN, Rose S. Is functional dyspepsia of particular concern in women? A review of gender differences in epidemiology, pathophysiologic mechanisms, clinical presentation, and management. Am J Gastroenterol. 2006 Dec;101(12 Suppl):S644-53. Abstract

11. Vakil N, Stelwagon M, Shea EP, et al. Symptom burden and consulting behavior in patients with overlapping functional disorders in the US population. United European Gastroenterol J. 2016 Jun;4(3):413-22.Full text  Abstract

12. National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. Dec 2021 [internet publication].Full text

13. Yap PR, Goh KL. Non-steroidal anti-inflammatory drugs (NSAIDs) induced dyspepsia. Curr Pharm Des. 2015;21(35):5073-81. Abstract

14. Tack J, Carbone F. Functional dyspepsia and gastroparesis. Curr Opin Gastroenterol. 2017 Nov;33(6):446-54. Abstract

15. Flook N, Unge P, Agreus L, et al. Approach to managing undiagnosed chest pain: could gastroesophageal reflux disease be the cause? Can Fam Physician. 2007 Feb;53(2):261-6.Full text  Abstract

16. Chang AM, Fischman DL, Hollander JE, et al. Evaluation of chest pain and acute coronary syndromes. Cardiol Clin. 2018 Feb;36(1):1-12. Abstract

17. Thomson AB, Barkun AN, Armstrong D, et al. The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment - prompt endoscopy (CADET-PE) study. Aliment Pharmacol Ther. 2003 Jun 15;17(12):1481-91.Full text  Abstract

18. Kapoor N, Bassi A, Sturgess R, et al. Predictive value of alarm features in a rapid access upper gastrointestinal cancer service. Gut. 2005 Jan;54(1):40-5.Full text  Abstract

19. Talley NJ. What the physician needs to know for correct management of gastro-oesophageal reflux disease and dyspepsia. Aliment Pharmacol Ther. 2004;20(suppl 2):S23-30. Abstract

20. Vakil N, Moayyedi P, Fennerty MB, et al. Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis. Gastroenterology. 2006 Aug;131(2):390-401. Abstract

21. Expert Panel on Gastrointestinal Imaging., Vij A, Zaheer A, et al. ACR Appropriateness Criteria® Epigastric Pain. J Am Coll Radiol. 2021 Nov;18(11s):S330-S339.Full text  Abstract

22. Talley NJ. How to manage the difficult-to-treat dyspeptic patient. Nat Clin Pract Gastroenterol Hepatol. 2007 Jan;4(1):35-42. Abstract

23. Sundar N, Muraleedharan V, Pandit J, et al. Does endoscopy diagnose early gastrointestinal cancer in patients with uncomplicated dyspepsia? Postgrad Med J. 2006 Jan;82(963):52-4.Full text  Abstract

24. Moayyedi PM, Lacy BE, Andrews CN, et al. ACG and CAG clinical guideline: management of dyspepsia. Am J Gastroenterol. 2017 Jul;112(7):988-1013.Full text  Abstract

25. Best LM, Takwoingi Y, Siddique S, et al. Non-invasive diagnostic tests for Helicobacter pylori infection. Cochrane Database Syst Rev. 2018 Mar 15;(3):CD012080.Full text  Abstract

26. Talley NJ, Vakil N, Lauritsen K, et al. Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response? Aliment Pharmacol Ther. 2007 Sep 1;26(5):673-82.Full text  Abstract

27. van Zanten SV, Flook N, Talley NJ, et al. One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled study. Aliment Pharmacol Ther. 2007 Sep 1;26(5):665-72.Full text  Abstract

28. van Zanten SV, Armstrong D, Chiba N, et al. Esomeprazole 40 mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled "ENTER" trial. Am J Gastroenterol. 2006 Sep;101(9):2096-106. Abstract

29. Pinto-Sanchez MI, Yuan Y, Hassan A, et al. Proton pump inhibitors for functional dyspepsia. Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011194.Full text  Abstract

30. Ford AC, Ching E, Moayyedi P. Meta-analysis: yield of diagnostic tests for coeliac disease in dyspepsia. Aliment Pharmacol Ther. 2009 Jul;30(1):28-36. Abstract